| |
 |
Editorial [Hot Topic: Delivery, Intracellular Trafficking, and Biological Effectiveness of Oligonucleotide-Based Therapeutics Executive Editor: A. Mescalchin and G. Sczakiel]
|
| |
|
pp.3601-3602 (2) Authors: Alessandra Mescalchin, Georg Sczakiel
|
| |
|
|
| |
|
Cellular Delivery In Vivo of siRNA-Based Therapeutics
|
| |
|
pp.3603-3619 (17) Author: A. Aigner
|
| |
|
|
| |
|
Targeting the Lung Using siRNA and Antisense Based Oligonucleotides
|
| |
|
pp.3620-3627 (8) Authors: Sterghios A. Moschos, Karen Spinks, Andrew E. Williams, Mark A. Lindsay
|
| |
|
|
| |
|
Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins
|
| |
|
pp.3628-3636 (9) Author: Frank Edenhofer
|
| |
|
|
| |
|
Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
|
| |
|
pp.3637-3655 (19) Authors: S. D. Laufer, T. Restle
|
| |
|
|
| |
|
Peptide-Based Nanoparticle for Ex Vivo and In Vivo Dug Delivery
|
| |
|
pp.3656-3665 (10) Authors: Laurence Crombez, May Catherine Morris, Sebastien Deshayes, Frederic Heitz, Gilles Divita
|
| |
|
|
| |
|
Phosphorothioate-Stimulated Cellular Uptake of siRNA: A Cell Culture Model for Mechanistic Studies
|
| |
|
pp.3666-3673 (8) Authors: A. Detzer, M. Overhoff, A. Mescalchin, M. Rompf, G. Sczakiel
|
| |
|
|
| |
|
siRNA Modifications and Sub-Cellular Localization: A Question of Intracellular Transport?
|
| |
|
pp.3674-3685 (12) Authors: T. Ohrt, P. Schwille
|
| |
|
|
| |
|
Delivery of siRNA to the Target Cell Cytoplasm: Photochemical Internalization Facilitates Endosomal Escape and Improves Silencing Efficiency, In Vitro and In Vivo
|
| |
|
pp.3686-3697 (12) Authors: S. Oliveira, A. Hogset, G. Storm
|
| |
|
|
